Cargando…
Author Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873230/ https://www.ncbi.nlm.nih.gov/pubmed/33563903 http://dx.doi.org/10.1038/s41408-021-00413-7 |
| _version_ | 1783649342451613696 |
|---|---|
| author | Locatelli, Franco Zugmaier, Gerhard Mergen, Noemi Bader, Peter Jeha, Sima Schlegel, Paul-Gerhardt Bourquin, Jean-Pierre Handgretinger, Rupert Brethon, Benoit Rossig, Claudia Chen-Santel, Christiane |
| author_facet | Locatelli, Franco Zugmaier, Gerhard Mergen, Noemi Bader, Peter Jeha, Sima Schlegel, Paul-Gerhardt Bourquin, Jean-Pierre Handgretinger, Rupert Brethon, Benoit Rossig, Claudia Chen-Santel, Christiane |
| author_sort | Locatelli, Franco |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7873230 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78732302021-02-16 Author Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study Locatelli, Franco Zugmaier, Gerhard Mergen, Noemi Bader, Peter Jeha, Sima Schlegel, Paul-Gerhardt Bourquin, Jean-Pierre Handgretinger, Rupert Brethon, Benoit Rossig, Claudia Chen-Santel, Christiane Blood Cancer J Correction Nature Publishing Group UK 2021-02-01 /pmc/articles/PMC7873230/ /pubmed/33563903 http://dx.doi.org/10.1038/s41408-021-00413-7 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correction Locatelli, Franco Zugmaier, Gerhard Mergen, Noemi Bader, Peter Jeha, Sima Schlegel, Paul-Gerhardt Bourquin, Jean-Pierre Handgretinger, Rupert Brethon, Benoit Rossig, Claudia Chen-Santel, Christiane Author Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study |
| title | Author Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study |
| title_full | Author Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study |
| title_fullStr | Author Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study |
| title_full_unstemmed | Author Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study |
| title_short | Author Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study |
| title_sort | author correction: blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the rialto trial, an expanded access study |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873230/ https://www.ncbi.nlm.nih.gov/pubmed/33563903 http://dx.doi.org/10.1038/s41408-021-00413-7 |
| work_keys_str_mv | AT locatellifranco authorcorrectionblinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy AT zugmaiergerhard authorcorrectionblinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy AT mergennoemi authorcorrectionblinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy AT baderpeter authorcorrectionblinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy AT jehasima authorcorrectionblinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy AT schlegelpaulgerhardt authorcorrectionblinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy AT bourquinjeanpierre authorcorrectionblinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy AT handgretingerrupert authorcorrectionblinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy AT brethonbenoit authorcorrectionblinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy AT rossigclaudia authorcorrectionblinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy AT chensantelchristiane authorcorrectionblinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy |